Browsing: therapeutics

PTC Therapeutics, Inc. (NASDAQ: NASDAQ:) reported a robust financial performance in its second quarter of 2024, with a total revenue…

Check out the companies making headlines in midday trading: Ford Motor — The automaker’s stock fell more than 17% after…

Houston-based Alaunos Therapeutics, Inc. has announced a reverse stock split of its common stock at a ratio of 1-for-10, set…

The biotechnology sector is witnessing a paradigm shift as gene editing emerges as a transformative force in medicine. CRISPR Therapeutics…

In their Q1 2024 financial results conference call, Addex Therapeutics (NASDAQ: ADXN) provided updates on their research and development initiatives,…

Vivos Therapeutics, a company specializing in the treatment of obstructive sleep apnea (OSA), reported a total revenue of $3.4 million…

Fulcrum Therapeutics (ticker: NASDAQ:) has entered into a significant collaboration with Sanofi (NASDAQ:) for the development and commercialization of losmapimod,…

Updated Financial Article: Alnylam Pharmaceuticals’ Strategic Focus on RNAi TherapeuticsAlnylam Pharmaceuticals continues to demonstrate its leadership in the biopharmaceutical industry,…

TG Therapeutics (NASDAQ:) has reported a robust first quarter in 2024, with Briumvi, its anti-CD20 therapy, driving significant revenue growth.…

Panbela Therapeutics, Inc. (PBLA) has shared an update on its clinical programs and financials during its Fourth Quarter 2023 Earnings…